World Parkinson’s Day: A Time to Raise Awareness and Strengthen Support

Apr 11, 2025 | Non classé

April 11 marks World Parkinson’s Day – an opportunity to raise global awareness about Parkinson disease (PD) and acknowledge the experiences of those living with it, their families, and their caregivers. The day commemorates the birth of James Parkinson, who first described the condition in 1817.

Parkinson disease is a progressive neurological condition that impacts movement, cognitive health, sleep, and emotional wellbeing. While it is more commonly diagnosed in older adults, PD can affect people of all ages and backgrounds. Symptoms vary widely, from tremors and rigidity to mental health challenges and cognitive decline. There is currently no cure, but a combination of medicines, surgery, and rehabilitative therapies can help reduce symptoms and improve quality of life.

Pharmalys supports World Parkinson’s Day

At Pharmalys, we stand in solidarity with people living with Parkinson’s and the wider global community working to address the challenges posed by this condition. As an organisation committed to improving access to health data and research across underserved regions, we recognise the need for better diagnosis, earlier intervention, and more equitable access to therapies – especially in low- and middle-income countries where neurological services are often limited.

The World Health Organization’s Intersectoral global action plan on epilepsy and other neurological disorders including PD calls for stronger healthcare systems, better training for non-specialist providers, and greater investment in research and innovation to tackle PD and other neurological conditions.

How we can help

Improving understanding of Parkinson’s is key. We can all contribute by:

· Raising awareness to reduce stigma and misinformation

· Supporting caregivers and families with accessible resources

· Advocating for research and early detection

· Promoting equitable access to treatment and support services

On #WorldParkinsonsDay, Pharmalys reaffirms its commitment to supporting inclusive health initiatives that prioritise neurological care as part of a broader effort to strengthen health systems and improve outcomes for all.

 

Sources:

https://www.who.int/news-room/fact-sheets/detail/parkinson-disease

https://www.parkinsons.org.uk/get-involved/world-parkinsons-day

Pharmalys corporate social responsibility commitments

Pharmalys corporate social responsibility commitments

Pharmalys’ approach to corporate social responsibility reflects its long-standing commitment to advancing clinical research while contributing to sustainable and inclusive healthcare systems, particularly across the African continent. Structured around three core...

A recap from the first Pharmalys Voice of 2026

A recap from the first Pharmalys Voice of 2026

On 26 March 26 2026, Pharmalys held its first Pharmalys Voice meeting of the year, bringing together colleagues from across the company for an engaging and interactive virtual session. With a mix of insightful presentations, lively discussions and moments of fun, the...

Women’s economic power benefits everyone

Women’s economic power benefits everyone

Gender equality is a core challenge to be met. More than 95% of women worldwide live in economies that do not provide full legal equality. Even in economies that have modernised their laws, women still face constraints that limit the work they can do, the businesses...

Microplastics and human health: A growing public health concern

Microplastics and human health: A growing public health concern

Developed following the 19th century Industrial Revolution, plastics are synthetic or semi-synthetic polymers, categorised according to the chemical composition of their primary polymer and any side chains. These include acrylics, polyesters, silicones, polyethylenes...

A successful GCLP Audit at Institut Pasteur de Dakar, Senegal

A successful GCLP Audit at Institut Pasteur de Dakar, Senegal

Jeanette Young’s unit at Pharmalys plays a crucial role in advancing global excellence in Good Clinical Laboratory Practice (GCLP) through the delivery of highly specialised ad hoc services, including tailored GCLP trainings and comprehensive gap analyses for...

Delivering excellence under complexity: Lessons learnt from Africa

Delivering excellence under complexity: Lessons learnt from Africa

Pharmalys is an international Clinical Research Organisation (CRO) with a diverse team distributed across Europe, Asia, North America and Africa. Within our global portfolio, we support the execution of numerous clinical trials (CTs) in Africa. Across these projects,...

Jeanette Young Shares GCLP Quality Insights with the TASK Team

Jeanette Young Shares GCLP Quality Insights with the TASK Team

On Friday 13 March 2026, Jeanette Young, Laboratory Solutions & GCLP Team Lead at Pharmalys, delivered an insightful and engaging presentation at TASK HQ  in South Africa. TASK is a global clinical research organisation with an in-house laboratory currently...